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B
ones and teeth are the only structures within the body where calcium and phosphate participate as functional pillars. Despite their mineral nature, both organs are vital and dynamic. The histogenesis of bone is directly from mesenchymal connective tissue (intramembranous bone formation) or from preexisting cartilage (endochondral bone formation). Intramembranous bones are found in the mandibulo-craniofacial complex, ilium, clavicle, and scapula. 1 The intramembranous bone formation pathway is used when intraoral bone augmentation techniques are used by the surgeon. 2 Bone is composed of the outer cortical layer and the inner cancellous layer. The dense haversian systems of cortical bone provide skeletal strength. Interposed between the cortices is a three-dimensional lattice network of trabeculae that acts as a reservoir for active bone metabolism. This bony architecture is dynamic with a continuous remodeling to repair and shape the bone to ensure renewal of form and function.
The principles of osteogenesis, osteoconduction, and osteoinduction can be used to optimize therapeutic approaches to bone regeneration. 3 Osteogenesis has been described as the direct transfer of vital cells to the area that will regenerate new bone. Osteoconduction embraces the principle of providing the space and a substratum for the cellular and biochemical events progressing to bone formation. The space maintenance requirement for many of the intraoral bone augmentation procedures allows the correct cells to populate the regenerate zone. 4 Osteoinduction embodies the principle of converting pluripotential, mesenchymal-derived cells along an osteoblast pathway with the subsequent formation of bone. This concept was established in 1965, with heterotopic ossicle formation induced by the glycoprotein family of morphogens known as the bone morphogenetic proteins (BMPs). 5 Therapeutic bone reconstruction approaches use some or all of these principles in an attempt to maximize the clinical bone augmentation results.
BONE AUGMENTATION APPLICATIONS
Bone augmentation techniques may be used for the applications of extraction socket defect grafting, horizontal ridge augmentation, vertical ridge augmentation, and sinus augmentation. To maximize the results for each of these applications, a variety of different techniques is employed. They include particulate grafting, membrane use, block grafting, and distraction osteogenesis, either alone or in combination.
When considering the various modalities of treatment for the prosthetic replacement of teeth following tooth loss, the end goal of therapy is to provide a functional restoration that is in harmony with the adjacent natural dentition. Resorption of alveolar bone is a common sequela of tooth loss and presents a clinical problem, especially in the esthetic zone. This may jeopardize the esthetic outcome and compromise functional and structural aspects of treatment. To achieve this goal of therapy, it is desirable to provide treatment that will aim at preservation of the natural tissue contours in preparation for the proposed implant prosthesis. 6 However, augmentation and regeneration of the lost bone often are necessary. With the current increase in the use of dental implants for restoration of partial and complete edentulism, more emphasis is being placed on preservation of the alveolar ridge to ensure optimal implant placement and prosthetic treatment outcome. To satisfy the goals of implant dentistry, hard and soft tissues need to be present in adequate volumes and quality. To achieve an optimized restorative result, clinicians are often faced with placing implants in anatomically less favorable positions with regards to the quantity of available bone. This has necessitated development of techniques and materials that promote predictable regenerative treatment. Regeneration refers to the reconstitution of a lost or injured part by complete restoration of its architecture and function. 7 Augmentation of bone volume has been assisted through different methods, including use of growth and differentiation factors, particulate and block grafting materials, distraction osteogenesis, and guided bone regeneration (GBR). These techniques resulted in comparable long-term implant survival. 8 Alveolar ridge deformities are classified according to their morphology and severity. 9, 10 A classification for alveolar ridge defects has been described to standardize communication among clinicians in the selection and sequencing of reconstructive procedures designed to eliminate these defects. 9 A class I defect has bucco-lingual loss of tissue with normal ridge height in an apicocoronal direction. A class II defect has apico-coronal loss of tissue with normal ridge width in a bucco-lingual direction. A class III defect has a combination bucco-lingual and apico-coronal loss of tissue resulting in loss of height and width. Thus, the bone augmentation technique employed to reconstruct these different ridge defects is dependent on the horizontal and vertical extent of the defect. The predictability of the corrective reconstructive procedures is influenced by the span of the edentulous ridge and the amount of attachment on the neighboring teeth; typically, reconstructive procedures are less favorable in defects that exhibit horizontal and vertical components. The extent of the anticipated bone resorption varies between the mandible and maxilla and at sites within the arches.
Socket Preservation Application
In the anterior maxilla, where the buccal plate often is extremely thin and friable, consistent bone resorption is found after extraction. 11 To minimize bone resorption, less traumatic extraction techniques with socket augmentation, using a variety of particulate bone graft materials with and without membrane barriers, were reported that demonstrated significantly reduced alveolar ridge dimensional changes associated with these preservation techniques. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Grafting of extraction sockets at the time of extraction may not always be beneficial. Animal and human studies showed that extraction sockets with completely intact bony walls are capable of socket defect bone regeneration on their own. [22] [23] [24] Despite preservation of the alveolar ridge and socket dimensions through the use of a variety of bone graft materials, the dynamics of the extraction socket healing processes reportedly were altered. 25 Fibrous graft material encapsulation was shown following grafting of extraction sockets in the absence of barrier membranes that may influence the bone-implant contact following implant integration. 25, 26 Multiple animal studies showed that defects of the original buccal plate do not heal completely without use of a grafting technique. [27] [28] [29] Thus, in the anterior maxilla, grafting for space maintenance and ridge preservation may be beneficial. 30 In addition, for situations where the periapical bone or the socket walls are not intact, bone augmentation may be used to preserve the original anatomy of any location. Although socket preservation surgery is beneficial in some cases, soft tissue closure and graft containment are two of the difficulties associated with this procedure. [30] [31] [32] To preserve the extraction socket architecture and to accelerate the timeline to final implant restoration, the technique of immediate implant placement at the time of extraction often is proposed. Immediate implant placement was shown to have a failure rate of <5%, which is comparable to delayed placement. 15, 31, 32 Many reports demonstrated successful outcome with GBR applied to dental implants placed in extraction sockets. 15, 33 The immediate placement of implants into fresh extraction sockets in conjunction with bone augmentation has shown comparable success to that observed in delayed implant placement. 15, 31, 34 Several approaches were reported that included the use of expanded polytetrafluoroethylene § (ePTFE) membranes, 15, 31, 35 bioabsorbable membranes, 36 demineralized freeze-dried bone allograft (DFDBA), 31, 37, 38 freeze-dried bone allograft (FDBA), 37 bone autograft, 25, 39 hard tissue replacement polymer, 40 connective tissue barriers, 41, 42 bone xenograft, and hydroxyapatite (HA); 38, 43 none showed a superior outcome to others. Membrane exposure was associated with higher bone resorption. Immediate postextraction implant placement should be considered only if implant stability can be achieved; otherwise, a staged approach is used. Conversely, immediate placement of implants into extraction sockets with a horizontal defect dimension (distance from bone to implant) <2 mm is amenable to predictable partial defect fill by appositional bone growth, without barrier membranes. 34, 39, 44 The degree of bone-implant integration is highly dependent on the gap present between the inner aspect of the socket and implant surface. 45 The degree of bone fill and the extent of implant thread exposure of immediate implants placed into extraction sockets have been evaluated. 15, 46 The thread exposure for immediate implants was greater when complications, such as membrane exposure, occurred during healing. 15 Healing with immediate implants is similar to extraction sockets alone; however, the vascularity is compromised for the overlying soft tissue with the implant in place, resulting in potentially more soft tissue healing complications. 46 Ridge Augmentation Application Critical-sized alveolar ridge defects in the horizontal and vertical dimensions may occur following tooth loss, fractures, or pathologic processes. Such defects may compromise the ideal implant placement as prescribed prosthetically with an unfavorable outcome. Horizontal ridge augmentation was described with the use of a variety of different techniques and materials. [47] [48] [49] [50] [51] Although achieving comparable clinical outcomes for vertical ridge augmentation has been more challenging, success was demonstrated with the use of non-resorbable ePTFE membranes with autograft, [52] [53] [54] [55] titanium mesh with particulate grafts, 56 forced tooth eruption, 57 autogenous block grafting, 58 and distraction osteogenesis. 59, 60 Sinus Augmentation Application The posterior maxilla creates a unique challenge when minimal bone height remains inferior to the sinus floor. The inadequate bone volume often encountered is a result of a combination of ongoing maxillary sinus pneumatization and normal postextraction bone atrophy. The residual ridge height was measured in the edentulous posterior maxilla, and 43% of the proposed implant sites had £4 mm of bone crestal to the sinus. 61 To compound the challenges in this area further, the posterior maxilla has a poorer bone quality compared to the mandible, with the highest percentage of type IV bone. 62 Implant therapy in the posterior maxilla often is accomplished using shorter length implants. When an unfavorable crown/ root ratio is anticipated, augmentation of the alveolar bone height should be considered. In the absence of an intraoral component of vertical ridge deficiency, augmentation of the maxillary sinus floor through a modified posterior Caldwell-Luc procedure may be performed. [63] [64] [65] [66] This involves a lateral approach via a trap door access to the maxillary sinus. Careful elevation of the Schneiderian membrane creates a defined space between itself and the sinus floor to receive the bone-grafting material of choice. No significant difference in the failure rate was found with simultaneous implant placement and sinus augmentation compared to a delayed two-stage approach (Fig. 1) . 67, 68 In humans, several techniques were reported for successful sinus augmentation, with average implant success rates ;92%. 68, 69 As an alternative, sinus augmentation can be performed by a less invasive osteotome technique, where elevation of the sinus floor is performed by inward collapse of the residual crestal floor with specially designed osteotomes; this obviates the need for a trap door access. 51, 66, [70] [71] [72] [73] [74] [75] Bone graft material can be introduced through the prepared osteotomy, if needed, with or without simultaneous implant placement. The amount of augmentation achieved by the osteotome technique was 3 to 5 mm. Dependent on the proposed length of implant, a minimum preoperative ridge height of 5 mm is desired to achieve adequate elevation of the sinus floor without undue risk for perforation of the Schneiderian membrane. 76 Although the lateral window approach has a more extensive literature support, 77 the approach is determined by anatomic factors, such as the preoperative alveolar bone height and width dimensions and access, as well as the extent of the desired augmentation. When bone of sufficient volume and quality for achieving primary implant stabilization is present at the time of sinus augmentation, a single-stage approach may be used where implant placement is performed simultaneously. 67 Survival of implants placed at the time of sinus augmentation using the lateral window approach is increased with crestal ridge heights >3 mm. [78] [79] [80] Augmentation of the sinus has been described using a variety of grafting materials that include autogenous particulate bone graft, 61, 81, 82 DFDBA particulate, 83, 84 anorganic bovine bone particulate, 81, 85, 86 non-resorbable HA, 87 autogenous block grafts, 88 and BMP-2. 89 The placement of bioabsorbable or non-resorbable barrier membranes over the lateral sinus window and graft material aided in graft containment, prevented soft tissue encleftation, and enhanced the implant success rate. 90, 91 Histologic investigations of the regenerated bone following sinus augmentation procedures showed considerable variation in bone quality. Histomorphometric analysis of sinus graft biopsies revealed a large variation, typically 5% to 60%, in vital bone area. 61, 81, [92] [93] [94] [95] To evaluate for maxillary sinus pathology and to determine the anatomic features, such as residual bone, sinus topography, and septa locations, prior to initiation of a sinus augmentation procedure, a computer tomography scan evaluation may be performed. 66, 96, 97 Evidence of acute sinusitis, chronic sinusitis, or other sinus pathology suggests the need to refer to the otolaryngologist for treatment prior to initiation of the sinus augmentation procedure. 98 Preoperative sinusitis was a positive predictive factor for the development of postoperative acute sinusitis. 99 Although significant complications with sinus augmentation have a low incidence, the following have been reported: infection, bleeding, cyst formation, graft slumping, membrane tears, ridge resorption, soft tissue encleftation, sinusitis, and wound dehiscence. 90, 94, [100] [101] [102] In cases with smaller internal sinus angles, there was an increase in the incidence of membrane tears. 81 If the membrane tears, a bioabsorbable collagen membrane can be used to assist in graft containment. Antibiotic prophylaxis preoperatively and for 7 to 10 days postoperatively with amoxicillin or clavulanic acid and amoxicillin were suggested. 87, 102, 103 Although these studies did not evaluate treatment without antibiotics, antibiotic prophylaxis reduced the infection rate for oral surgery procedures. 104 
BONE AUGMENTATION TECHNIQUES
The remainder of this article reviews the various techniques available for augmenting the quantity of the available deficient alveolar bone. These include, but are not limited to, the use of barrier membranes for GBR, particulate grafting materials, onlay block grafting techniques, distraction osteogenesis, ridge split techniques, the future applications of molecular factors to stimulate the rate of bone formation, and in severe defects, a combination staged approach of these techniques.
Bone Augmentation With Barrier Membrane Technique
The concept of GBR was described first in 1959 when cell-occlusive membranes were employed for spinal fusions. 105 The terms ''guided bone regeneration'' and ''guided tissue regeneration'' (GTR) often are used synonymously and rather inappropriately. GTR deals with the regeneration of the supporting periodontal apparatus, including cementum, periodontal ligament, and alveolar bone, whereas GBR refers to the promotion of bone formation alone. GBR and GTR are based on the same principles 106,107 that use barrier membranes for space maintenance over a defect, promoting the ingrowth of osteogenic cells and preventing migration of undesired cells from the overlying soft tissues into the wound. Protection of a blood clot in the defect and exclusion of gingival connective tissue and provision of a secluded space into which osteogenic cell from the bone can migrate are essential for a successful outcome. The sequence of bone healing is not only affected by invasion of A direct lateral window approach sinus augmentation procedure with simultaneous implant placement.
non-osteogenic tissue, but more so by the defect size and morphology. A predictable intraoral GBR approach was developed in the late 1980s and early 1990s; [108] [109] [110] it has become a predictable surgical methodology to enhance new bone formation in peri-implant bone deficiencies and alveolar ridge augmentation, albeit requiring excellent surgical skills and being highly technique sensitive. The technique can be applied to extraction socket defects, horizontal and vertical ridge augmentation, and the correction of dehiscence and fenestration defects around implants. Successful vertical ridge augmentation with the GBR technique, using titanium reinforced ePTFE membranes, was shown in human and animal studies. 54, 111 Both studies demonstrated that up to 4 mm of vertical augmentation was feasible without the use of any grafting material under the membranes. Addition of bone graft material to the GBR technique increases the amount of achievable vertical regeneration. 55 In follow-up prospective studies, survival of prosthetically loaded implants placed in ridges that were augmented vertically with various GBR techniques, using non-resorbable membranes with or without a bone graft, demonstrated comparably favorable outcomes as implants placed in native or horizontally augmented bone, with an overall success rate of 97.5%. [112] [113] [114] [115] A variety of non-resorbable and bioabsorbable barrier membranes has been used in bone augmentation with the GBR concept. From a manufacturing aspect, these devices should feature characteristics necessary to attain specific goals when applied in GBR, including material biocompatibility and stability over the required duration of barrier function, space maintenance, exclusion of undesired cell ingrowth, and ease of use. Nonresorbable barriers are available as ePTFE, titanium reinforced ePTFE, high-density PTFE, or titanium mesh. 49, [116] [117] [118] [119] An evidence-based outcomes assessment for the different GBR approaches summarized the effectiveness of the technique in bone augmentation. 49 The porous ePTFE membranes (guided tissue augmentation material, GTAM) have a central cell occlusive region and an outer cell adherent region; they can be obtained with titanium ribs for use in larger defects to enhance their space maintenance properties (Fig. 2) . 118 The ePTFE membrane has been studied extensively in animals and humans 47, 49, 109, 110 and is considered a standard for bone augmentation. 120 The high-density PTFE membranes k are entirely cell occlusive, show minimal inflammation when exposed to the oral cavity, do not integrate with the tissue for membrane stabilization, and were effective in a rat mandible model and in human case reports. 117, 121 The use of titanium mesh as a barrier maximizes graft containment and eliminates the space maintenance collapse problems that are associated with conventional membranes. 119, 122 The pattern of bone regeneration involves angiogenesis and ingress of osteogenic cells from the defect periphery toward the center to create a well-vascularized granulation tissue. This provides a scaffold for woven bone proliferation and bone apposition within the defect. 123 The size of the defect influences the bone healing capacity. In circumstances where the defect is too large to generate a biomechanically stable central scaffold, bone formation is limited to the marginal stable zone with a central zone of disorganized loose connective tissue. Thus, combined use of bone grafts or bone replacement substitutes with barrier membranes are advocated in bone regeneration of larger defects. Repair of osseous defects closely resembles appositional bone growth during which the woven bone construction acts as a template for lamellar bone formation. As in the healing pattern observed in extraction sockets, organization of the blood clot is followed by ingrowth of vascular tissue and deposition of woven bone. Reinforcement of this disorganized bone structure is accomplished by lamellar bone formation, which, in turn, is remodeled soon after as is evident by the presence of secondary osteons.
Maintenance of primary wound closure throughout the healing period is critical to the outcome of GBR. Despite the success demonstrated with ePTFE membranes in GBR application, complications of soft tissue dehiscence with membrane exposure and infection impaired the outcome of therapy with a decreased gain in bone fill reported. 124, 125 To overcome some of the limitations of non-resorbable membranes, such as the need for a second surgical procedure for their removal with the added risk of loss of some of the regenerated bone further to flap reflection, they largely have been replaced with bioabsorbable membranes. 15, 35, 51, [126] [127] [128] [129] Bioabsorbable barrier membranes currently in clinical use fall into two broad categories: natural or synthetic. Natural products are made of various types of collagen of animal origin. Synthetic products are made of aliphatic polyesters, primarily poly(lactic) and poly(glycolic) acid copolymers. They differ in their mode of resorption; collagen products undergo enzymatic degradation, whereas synthetic barriers are degraded by hydrolysis. 130 Like the non-resorbable membranes, bioabsorbable membranes can experience premature soft tissue dehiscences and exposures. However, communication with the oral cavity accelerates their resorption rate, and, thus, reduces prolonged contamination of the regenerated bone matrix. Although collagen barriers offered improved soft tissue response, they lacked the ability to maintain adequate defect space. 27, 131, 132 Collagen barriers promoted human osteoblast proliferation and alkaline phosphate activity. 133 Degradation of synthetic copolymers elicited a soft tissue inflammatory response that resulted in resorption of some of the regenerated bone. 134 In addition, there is high variability and lack of control over the rate of membrane resorption, which is influenced by factors such as the local pH and material composition.
Bioabsorbable barriers have been developed in synthetic polymer forms ¶# ** † † ‡ ‡ (including [polyglactin 910] mesh), § § collagen, kk ¶ ¶## *** † † † ‡ ‡ ‡ § § § calcium sulfate, kkk or intact connective tissue. ¶ ¶ ¶36, 51, [135] [136] [137] [138] One of the collagen membranes ### had a barrier function in animal studies up to 4 months. 27 These collagen products**** † † † † ‡ ‡ ‡ ‡ are used only for initial graft material containment and clot stabilization because of their rapid 1-to 2-week resorption time. 30, 135, [138] [139] [140] A polymer membrane § § § § was evaluated and found to be successful in humans for use as a GBR barrier in combination with particulate grafting. 90, 136 Because of a lack of rigidity, in all but the smallest defects, most of these bioabsorbable membranes must be used in combination with a graft material for space maintenance in bone augmentation applications. 27 One collagen membrane kkkk was studied in clinically relevant implant defects in animals 27 and was evaluated around implants in humans. 51 This membrane performed in a manner similar to ePTFE with respect to defect fill and showed less soft tissue exposure problems compared to the ePTFE control group.
Choice of membrane depends largely on the required duration of membrane function for tissue regeneration (;6 months). 141, 142 The volume of regenerated bone generally is more encouraging with non-resorbable ePTFE membranes than with bioabsorbable membranes 143, 144 Contrasting findings also have been reported. The non-resorbable ePTFE (GTAM) membrane was compared to a bioabsorbable collagen barrier ¶ ¶ ¶ ¶ in 84 defects. An average of 92% bone fill was achieved with the collagen membrane/ xenograft compared to 78% with ePTFE/xenograft. 51 When no premature membrane exposure occurred, nearly complete defect fill resulted. However, in 16% of the collagen membrane cases and 24% of the ePTFE cases, membrane exposure was present at the time of suture removal; ultimately, 44% of the ePTFE membranes had to be removed prematurely. A staged technique using autograft and ePTFE membranes (GTAM) was described in 40 cases of horizontal ridge augmentation. 47 Successful application of bioabsorbable membranes in the treatment of a variety of horizontal and vertical bone defects, including implant dehiscence and fenestration type defects, has been reported. 36, 139, 145, 146 Perforation of the cortical bone layer has been advocated in GBR, because it was postulated that this increases the vascularity of the wound and releases growth factors and cells with angiogenic and ¶ osteogenic potential. 123 Although no evidence exists in the literature regarding a performance advantage, numerous membrane fixation products exist for improved graft containment and minimization of membrane micromotion. 147 Membrane micromotion was hypothesized to decrease the regenerative response by forming a layer of soft tissue under the membrane. 125 Products that are available to stabilize membranes include non-resorbable mini screws and tacks 47, 147 and bioabsorbable tacks made from polylactic acid. 148 A pair of studies used fixation techniques as part of the experimental protocol. 118, 134 Particulate Bone Grafting Technique A bone graft is a tissue or material used to repair a defect or deficiency in contour and/or volume. There is a diversity of opinion regarding what particulate materials should be used for typical clinical applications, the rationale for their use, the rationale for using combinations of materials, and the percentages of each material used in combination. 25, [149] [150] [151] Bone grafts fall into four general categories: autografts, allografts, xenografts, and alloplasts. The use of these materials in regenerative procedures is based on the assumption that they possess osteogenic potential (contain bone-forming cells), are osteoinductive (contain boneinducing substances), or simply are osteoconductive (serve as a scaffold for bone formation). Autogenous bone harvested from intraoral or extraoral sites is the most predictable osteogenic organic graft for osseous tissue regeneration. 50, 61, 152, 153 Extraoral sites, such as the iliac crest, provide adequate quantity of graft material with excellent osteogenic, osteoinductive, and osteoconductive properties, but have a high morbidity related to the second surgical site. With the limited availability of intraoral sites, donor site morbidities, and inadequate quantity of the harvested bone, the use of other grafting materials has been advocated whenever possible.
The autograft, allograft, alloplast, and xenograft materials all have reported success, alone or in combination, for particulate bone augmentation. 3 The particulate autograft is the gold standard for most craniofacial bone grafting, including the treatment of dental implant-related defects. 50, 61, 153 Several studies demonstrated the effectiveness of particulate autograft. 52, 53, 82, 118 However, autografts have recognized limitations, such as donor site morbidity, increased cost, potential resorption, size mismatch, and an inadequate volume of graft material. 154, 155 Allografts are grafts transferred between members of the same species, which are genetically dissimilar. They have the advantage of being available in higher quantities and eliminate the morbidity associated with a second surgical site. The allograft has been used as a substitute for autografts or as an autograft expander. 156 Current usage primarily is in particulate form, although putty, gel, collagen sponge, sheets, and cortical and cancellous segments also are used. Biochemical extraction techniques showed that growth and differentiation factors are present in DFDBA preparations. [157] [158] [159] [160] However, some reports revealed unpredictable or poor bone formation with some lots of commercially available DFDBA. 159, 161, 162 The use of particulate allograft bone replacement substitute has been reported for numerous applications, including sinus augmentation, 86, 163 ridge augmentation, 54, 164 and in extraction socket applications. 164 In a comparative study using FDBA or DFDBA for localized ridge and sinus augmentation, histologic observations showed regeneration of ;42% new bone area with no statistical difference between the two materials. 37 Although the risk for disease transmission essentially is non-existent, concern still exists for some patients and estimates for the risk were reported. 165, 166 This has, in part, fueled attempts to identify alternative bone graft substitutes, such as those made from synthetic materials.
Advances in the field of biomaterials and the limitations associated with the use of autografts and allografts have directed attention toward the use of alloplastic graft materials. 167 These synthetic bone graft materials are osteoconductive and have no intrinsic potential for osteogenesis or induction. Osteoconduction provides for the ingrowth of capillaries, perivascular tissues, and osteoprogenitor cells from the adjacent recipient bed. 168 Additionally, there is no practical restriction to the available quantity of graft, and the risk for disease transmission and need for harvesting bone tissue are eliminated. They have been used successfully in dental surgical specialties in alveolar ridge preservation and augmentation 169 and sinus graft procedures. 170, 171 Bone augmentation techniques using synthetic graft materials (i.e., alloplasts) have demonstrated potential in surgical therapy for >100 years. 172 Calcium sulfate and calcium phosphate compounds are attractive alternatives to autografts because of their biocompatibility, handling characteristics, porosity, different rates of dissolution, chemical and physical resemblance to bone mineral, and potentially unlimited supply at a modest cost. [173] [174] [175] [176] [177] Granular porous HA has been considered a unique alloplast, in that it is formed by the hydrothermal chemical conversion of sea coral from biogenic carbonate to HA. 178 Ridge augmentation with HA particulate, with and without autogenous bone or plaster, was reported. 179 Sinus augmentation with HA showed success and excellent dimensional stability. 67, 85, 87 The second generation of calcium phosphate bone cements has shown promise in orthopedic and maxillofacial reconstruction, which also could indicate a use in implant reconstruction. 176 The use of xenografts for bone grafting was reported in 1889. 180 Xenografts are derived from another species and are considered to be biocompatible and osteoconductive. Bovine-derived particulate preparations that have the organic components removed demonstrated successful bone regeneration in numerous human bone augmentation studies. 51, 86, 163, 181 Many of these xenograft materials have the potential to resorb and be replaced with host bone over time. 100, 181, 182 Although having limited evaluation in bone augmentation application, the percentage area of bone fill in a bilateral sinus augmentation case report that compared a mixture of a xenograft #### plus autogenous bone to the same xenograft containing the collagen cell-binding domain peptide P-15***** alone was reported. 183 (The peptide component, P-15, is a synthetic clone of the 15 amino acid sequence of type I collagen that is involved uniquely in the binding of connective tissue cells. 184 ) The investigators reported that at 4 months, histomorphometric analysis revealed that the peptide component-treated side had similar quantity of bone to the xenograft/autogenous bone-grafted side of 8 months, suggesting an accelerated bone fill in the presence of the P-15 component. 183 Because the observations were based on one case, the validity of the treatment concept cannot be forecast adequately from such a small sample size. The use of the peptide component alone 185 and in combination with autogenous bone or another xenograft 186 was reported in other sinus augmentation applications. Although the amount of new bone formation achieved among the various biomaterials used did not show statistical significance, and the use of the peptide component has been advocated as a suitable substitute for autogenous bone, the lack of a true control in the study design makes extrapolation of findings difficult clinically. Further controlled studies are warranted to assess the value of these xenografts in ridge augmentation application.
Block Grafting Approaches
When using autogenous block graft approaches for bone augmentation, a considerable amount of horizontal augmentation can be added predictably to the defect area. 47, [187] [188] [189] A recent study on 115 autogenous block grafts reported only one complete failure where the block graft was removed. 189 The stabilization and intimate contact of these block grafts to the recipient bed has been considered crucial to a successful outcome. 190, 191 This can be achieved with the use of bone fixation screws 47, 192 (Fig. 3) or the simultaneous placement of dental implants 113, [193] [194] [195] Aggressive recipient bed preparation with decortication, intramarrow penetration, and inlay shaping also has been supported, because of increases in the rate of revascularization, the availability of osteoprogenitor cells, and the increased rate of remodeling. 163, 189, 190, [196] [197] [198] The healing of autogenous block grafts has been described as ''creeping substitution'' where viable bone replaces the necrotic bone within the graft 199 and is highly dependent on graft angiogenesis and revascularization. A variety of autologous onlay bone graft techniques has been used for the entire severely resorbed edentulous maxilla and mandible. 193, 200, 201 Although results have improved from the initially reported 50% failure rates, 193 graft resorption, complications, and implant survival rates are still a concern for these full-arch grafting procedures. 58, 202 The primary locations for harvesting intraoral block grafts include the external oblique ridge of the posterior mandible, symphysis, and ramus. 50, 187, 203 With bone defects >2 cm, an extraoral autogenous bone harvest from the iliac crest, cranium, or tibia is used often. 50 In addition to the ease of intraoral harvest, grafts derived from intramembranous bone have less resorption than endochondral bone. 204 Resorption rates of 0% to 25% 58, 205, 206 at the time of implant placement and up to 60% 207 at abutment connection were documented with the use of autogenous block grafts. With regard to graft resorption, an optimized outcome for ridge augmentation with block grafts is achieved with barrier membranes. 47, 208, 209 A recent human study showed a 17% resorption of mandibular block grafts used in combination with particulate autograft and xenograft for vertical ridge augmentation, with an average gain of ;5 mm. 58 This study also demonstrated retained vitality of the block autografts. Block grafts are harvested as corticocancellous or A block graft, harvested from the ramus, secured with fixation screws. Note perforations within the block graft and the recipient bed (not shown) allowing for an increase in the rate of revascularization, the availability of osteoprogenitor cells, and the increased rate of remodeling.
cortical bone autografts. The revascularization of corticocancellous block grafts takes place at a much faster rate than in cortical bone autografts 210 and at a slower rate than particulate autografts. 211 Revascularization of block grafts enables maintenance of their vitality, and, hence, reduces chances of graft infection and necrosis. Many studies demonstrated maintenance of intramembranous block graft vitality. 192, 212, 213 Although autogenous bone grafts (as block or particulate form) remain the gold standard for ridge augmentation, donor site morbidity associated with block graft harvest has turned attention to the use of allogenic block graft materials (Fig. 4) . Case reports demonstrated success with FDBA and DFDBA block graft material for application in horizontal ridge augmentation procedures. [214] [215] [216] However, further comparative studies are warranted to evaluate the healing of these allogenic blocks histologically.
Combination Approaches
With reference to GBR techniques and based on the aforementioned observations, it is assumed that grafting of large bone defects may be advantageous to preserve the present bone tissue and increase the volume of regenerated bone. The use of graft material in nonspace-making bone defects also provides for additional membrane support and prevents their collapse and occlusion of the space into which bone regeneration is anticipated. Membranes may be used in combination with block grafts and/or particulate graft materials to maximize the regenerative outcome (Fig. 5) . 49, 53, 217, 218 This combination approach can be used for more involved defects than those applicable for the individual approaches alone. 218, 219 Without underlying graft materials or reinforcement with the use of tenting screws, 220 barrier membranes may be compressed into the space of the bony defect by the overlying soft tissue during healing. 27, 49, 123, 221 In many situations, a membrane may not be required, and the graft material alone can be effective. 219 In some reports, 192, 222 resorption was reported with autografts when no membrane was used. In one report, 222 0.9 mm of the 3.6-mm grafted width increase was lost to resorption when the maxillary tuberosity was used, which may be a function of the type of donor bone. In another study, 209 significantly less resorption of the block grafts was found when ePTFE membranes were used to protect the graft. A histologic study 52 that used autograft and barrier membranes in humans revealed a bone-implant contact of 22% in the 4 mm of vertically regenerated bone, compared to the 44% found in native bone. A 5-year analysis 112 of the vertical augmentation with this approach demonstrated stable vertical gains.
Combination approaches may be applied to implant placement where the grafting procedure is performed at the time of implant surgery. This reduces the healing period and decreases the number of surgeries required and the morbidity and cost to the patient.
Ridge Expansion Techniques
Ridge splitting is an alternative to the various techniques described for horizontal ridge augmentation, including distraction osteogenesis (described later); it has a similar healing pattern and end result. 223, 224 With a narrow ridge, splitting the alveolar bone longitudinally, using chisels, osteotomes, or piezosurgical devices, 225 can be performed to increase the horizontal ridge width, provided the buccal and lingual cortical plates are not fused and some intervening cancellous bone is present. With adequate vascularity and stabilization of the mobile bone segment, together with sufficient interpositional bone grafting and soft tissue protection, a comparable result to alternate techniques can be obtained. 223, 224 A 5-year study 226 evaluating 449 implants placed in maxillary ridges expanded by the ridge split technique revealed a survival rate of 97%, which is consistent with placement in native bone. Recently, a modified two-phase approach to the ridge split technique was introduced that aims at minimizing the risk for unfavorable fractures of the segment in less flexible bone, as well as maintaining the segment vascularity during its expansion (Fig.  6 ). In the first surgery, a full-thickness mucoperiosteal flap is elevated on the buccal aspect of the ridge. A saw, bur, or piezosurgical device is used to perform the apical horizontal and proximal and distal vertical corticotomies. The crestal corticotomy can be made at the primary or secondary operation. The second surgery, a month later, involves the splitting and expansion of the ridge using osteotomes. At this stage, split-thickness buccal mucoperiosteal flap is elevated to preserve the vascularity of the buccal cortical plate. Implants can be placed in the space created between the buccal and lingual plates, with or without interpositional grafting. 223, 227, 228 The primary advantages of the ridge split technique using particulate, block graft, or GBR, compared to the mentioned lateral augmentation techniques, are reduced treatment time and reduced morbidity resulting from avoiding a separate donor site.
Distraction Osteogenesis
Distraction osteogenesis uses the long-standing biologic phenomenon that new bone fills in the gap defect created when two pieces of bone are separated slowly under tension. [229] [230] [231] [232] [233] Distraction of the segment can be achieved in a vertical and/or a horizontal direction. 234 The basic principles involved in distraction osteogenesis include a latency period of 7 days for initial post-surgical soft tissue wound healing, a distraction phase during which the two pieces of bone undergo gradual incremental separation at a rate of ;1 mm per day, and a consolidation phase that allows bone regeneration in the created space. 231, 235, 236 A number of case reports demonstrated the potential for successful results with a variety of alveolar bone distractors. 60, [237] [238] [239] [240] Distractor devices are of an intraosseous (Fig. 7) or extraosseous configuration (Fig. 8) . When the clinical requirement for significant vertical ridge augmentation exists, distraction osteogenesis can be used successfully with a variety of devices. 241 Thorough assessment and treatment planning is imperative for success. The prerequisites for optimal bone augmentation of defects using distraction osteogenesis are a minimum of 6 to 7 mm of bone height above vital structures, such as neurovascular bundles or air passages/sinus cavities, a vertical ridge defect of ‡3 to 4 mm, and an edentulous ridge span of three or more missing teeth. The height of bone on adjacent teeth acts as reference points for the extent of vertical gain that can be achieved. Improvement of attachment levels on teeth with distraction has not been successful in the animal model. 242 Therefore, compromised dentition with considerable bone loss may need to be extracted to create a true vertical component of 4 mm within the defect span. Smaller ridge defects of one or two teeth in width were associated with higher rates of complications when treated with the distraction technique. 243 In such cases, conventional ridge augmentation techniques should be used. 56, 58, 244 An intraosseous dental A) Application of two intraosseous distractors at time of site preparation for correction of a 7-mm mandibular anterior vertical defect. B) Radiographic view of an intraosseous distractor following distraction of the segment. Note that the bone segment is distracted beyond the desired level to allow for some vertical resorption typically observed during healing of the distracted segment. C and D) Gradual consolidation of the distracted osseous segment with good bone height maintenance around the loaded implants 3 years postoperatively.
implant-like distractor that was evaluated in dogs showed vertical gains of up to 9 mm in human case reports. 60, 239 Another device, with a small-diameter intraosseous approach, was used successfully for 9 mm of vertical movement prior to implant placement. 59 In contrast to these internal designs, an extraosseous distraction system with all moving components external to the cortical plate was developed and used successfully. 240, 245 The use of a prosthetic restorable distractor also was described showing a 4-to 6-mm increase in vertical height. 238 Data on implant success in distracted bone out 3 to 5 years showed favorable results comparable to other grafting approaches. 243 
FUTURE BONE AUGMENTATION APPROACHES
Future bone augmentation approaches likely will use molecular, cellular, and genetic tissue engineering technologies. 246 Numerous studies 13, [247] [248] [249] [250] evaluated these approaches; however, they have not received U.S. Food and Drug Administration (FDA) approval for bone augmentation use for dental implant reconstruction. The molecular approach using BMPs has received the most attention over the past decade. BMPs are differentiation factors that are part of the transforming growth factor superfamily. 176 They have multiple effects, including the ability to differentiate osteoprogenitor cells into mineral-forming osteoblasts. 5 Two of these proteins, BMP-2 and -7 (or osteogenic protein-1), have been cloned, studied extensively, and show promise for intraoral applications. 251, 252 Human studies 13, 247 demonstrated product safety with BMP-2 in ridge preservation and sinus augmentation applications. Although BMP-2 has been approved by the FDA for spinal fusion application, for human intraoral applications the carriers and dosage of BMP-2 and -7 are still under regulatory review and investigation. Although a large number of growth factors is being evaluated actively, plateletderived growth factor (PDGF) has received the most attention for intraoral use. 250 When the combination use of PDGF with ePTFE membranes around immediate implants was evaluated in dogs, PDGF with insulin growth factor showed more rapid bone formation than the negative control that included the carrier alone. 250 In another recent dog study 253 evaluating recombinant human PDGF-BB (rhPDGF-BB) and inorganic bone blocks for vertical bone augmentation application, test sites with rhPDGF-BB showed statistically significantly more vertical bone growth than controls. Recently, rh-PDGF combined with a tri-calcium phosphate (TCP) carrier at a concentration of 0.3 mg/ml was approved for periodontal regeneration. 254 As with the differentiation factors, the optimal carriers and growth factor dosages are still under investigation and regulatory review for intraoral bone augmentation use. The binding kinetics for growth and differentiation factors are substrate specific; therefore, to optimize the clinical outcome with different carriers, full binding and release evaluations need to be completed along with animal and human dosing studies.
Another growth factor approach is to use the patient's own blood, separating out the platelet-rich plasma (PRP) and adding this concentrated group of autogenous growth factors to the grafting material. 255 The addition of PRP to autogenous grafts showed a more rapid and dense bone formation compared to autogenous grafts used alone for bone augmentation. 255 An improvement in bone formation when PRP is added to other graft materials has not been demonstrated clearly. 68, 256 Gene therapy is a relatively new therapeutic modality based on the potential for delivery of altered genetic material to the cell. 257 Localized gene therapy can be used to increase the concentration of desired growth or differentiation factors to enhance the regenerative response. 258 With the current requirement for supraphysiologic BMP doses to obtain acceptable clinical results, this approach to deliver higher concentrations to the local bone augmentation site over longer periods of time shows promise. 249, 259 A cellular tissue engineering strategy that exploits the regenerative capacity of bone may include the in vitro amplification of osteoblast cells or osteoprogenitor cells grown within three-dimensional constructs. [260] [261] [262] Approaches specifically targeting intraoral bone augmentation demonstrated in vitro osteoblast amplification in different constructs. [262] [263] [264] Alternatively, the use of mesenchymal stem cells for construct seeding 265, 266 or development of an immortalized osteoblast line showed promise for bone regeneration. 267 These amplification approaches, in combination with gene therapy and molecular stimulation, may lead to improved approaches for multifactorial tissue engineering strategies aimed at alveolar bone augmentation. 258 
Figure 8.
An extraosseous distractor at placement.
CONCLUSIONS
Many techniques exist for effective bone augmentation. The approach largely is dependent on the extent of the defect and specific procedures to be performed for the implant reconstruction. It is most appropriate to use an evidenced-based approach when a treatment plan is being developed for bone augmentation cases.
